Form 4 for INVZ Innoviz Technologies Ltd.

Accepted 2026-05-04 08:49:42 ET · period of report 2026-04-30 · accession 0001178913-26-002357 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2026-05-04 08:49	2026-04-30	INVZ	Keilaf Omer David	CEO, Dir	J - Other	$0.00	-723.0K	3.51M	-17%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2026-04-30	J	D	723,019	$0.00	3,505,931	D	—	—	(F1) Represents a transfer of 723,019 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, pursuant to a divorce settlement. (F2) The amount includes 1,135,780 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 15,596 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 36,630 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 74,008 RSUs granted February 27, 2024, with 14,232 vesting quarterly through 2027 and 59,776 vesting quarterly through 2028; (d) 60,590 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 82,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 750,000 RSUs granted May 26, 2025, one-fourth vesting on May 26, 2026, remainder vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. (F3) No exercise price is applicable.